We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.21B
AUM Growth
+$330M
Cap. Flow
+$275M
Cap. Flow %
22.73%
Top 10 Hldgs %
36.41%
Holding
4,516
New
1,790
Increased
1,264
Reduced
722
Closed
680

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$135M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$54.5M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$24.8M
4
SMH icon
VanEck Semiconductor ETF
SMH
+$13.3M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$11.5M

Top Sells

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$60M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$30.3M
3
IWR icon
iShares Russell Mid-Cap ETF
IWR
+$20.3M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$17.2M
5
VO icon
Vanguard Morningstar Mid-Cap ETF
VO
+$13.2M

Sector Composition

Rank Sector Weight
1 Financials 6.31%
2 Technology 5.59%
3 Industrials 5.06%
4 Consumer Discretionary 3.68%
5 Healthcare 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVGR
4226
DELISTED
Avinger, Inc. Common Stock
AVGR
– –
0
– -$5K
CMLS
4227
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
– –
-14,270
Closed -$6K
MRNS
4228
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-1,300
Closed -$14.6K
NBSE
4229
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
– –
-177
Closed -$45K
EIGR
4230
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-5
Closed -$1K
BKCC
4231
DELISTED
BlackRock Capital Investment Corporation
BKCC
$0 ﹤0.01%
7
-1,807
-100% -$13.3K
BPTH
4232
DELISTED
Bio-Path Holdings Inc
BPTH
– –
-3
Closed -$4K
CYAN
4233
DELISTED
Cyanotech Corp
CYAN
– –
-54
Closed –
NVTA
4234
DELISTED
Invitae Corporation
NVTA
– –
-304
Closed -$2.89K
ARAV
4235
DELISTED
Aravive, Inc. Common Stock
ARAV
– –
-17
Closed -$2K
MRTX
4236
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-16,793
Closed -$62K
SRC
4237
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
– –
-67
Closed -$2.47K
SALM
4238
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
– –
-940
Closed -$7K
ONCT
4239
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
– –
-5
Closed -$4.5K
SCU
4240
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
– –
-1,728
Closed -$44K
JPS
4241
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
– –
-1,100
Closed -$11K
LTRPB
4242
DELISTED
Liberty TripAdvisor Holdings, Inc. Series B
LTRPB
– –
-80
Closed -$1K
SNLN
4243
DELISTED
Highland/iBoxx Senior Loan ETF
SNLN
– –
-284
Closed -$5K
INFI
4244
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-35,653
Closed -$44.3K
LOV
4245
DELISTED
Spark Networks SE American Depositary Shares
LOV
– –
-9,706
Closed -$9K
MTEM
4246
DELISTED
Molecular Templates, Inc.
MTEM
– –
-31
Closed -$2.68K
KDNY
4247
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$0 ﹤0.01%
6
-174
-97% -$10.3K
PDCE
4248
DELISTED
PDC Energy, Inc.
PDCE
– –
-1
Closed –
CS
4249
DELISTED
Credit Suisse Group
CS
– –
-14,004
Closed -$204K
SNMP
4250
DELISTED
Evolve Transition Infrastructure LP
SNMP
– –
-10
Closed -$4K
168 169
170
171 172

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
AP
Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2017 Portfolio in Review

As of Q3 2017, Tower Research Capital (TRC) held 4,516 positions worth $1.21B, up 37% from $881M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $275M of net new capital in Q3 2017, opening 1,790 new positions and adding to 1,264 existing holdings. Its largest new stake was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.

By sector, the portfolio is most concentrated in Financials at 6.3% of assets, up from 2.1% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $60M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2017 buy was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $60M.
  • Tower Research Capital (TRC) fully exited State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2017, selling an estimated $17.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $1.21B portfolio in Q3 2017.
  • Tower Research Capital (TRC) opened 1,790 new positions and closed 680 in Q3 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.21B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.